A significant discovery in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This essential cancer protector protein is frequently disabled in various forms of cancer, leading uncontrolled https://top10bookmark.com/story21796839/mini-antibodies-reactivate-p53-new-new-pathway-for-tumor-therapy